Literature DB >> 23783006

Acute Pisa syndrome after administration of a single dose of mirtazapine.

Antonio Méndez Guerrero1, Sara Llamas, Francisco José Murcia, Juan Ruíz.   

Abstract

Mirtazapine is an antidepressant with an adequate safety profile used in major depression. Adverse effects have been reported in the field of movement disorders, but none as truncal segmental dystonia (Pisa syndrome). We describe the case of a woman who developed Pisa syndrome after a single dose of mirtazapine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23783006     DOI: 10.1097/WNF.0b013e318297593d

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  2 in total

1.  Hypertensive urgency after administration of a single low dose of mirtazapine-a case report.

Authors:  Jiana Shi; Xiaojun Wang; Yin Ying; Lin Xu; Danyan Zhu
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

2.  Pisa syndrome associated with mirtazapine: a case report.

Authors:  Yuji Yamada; Harumasa Takano; Maki Yamada; Naoko Satake; Naotsugu Hirabayashi; Mitsutoshi Okazaki; Kazuyuki Nakagome
Journal:  BMC Pharmacol Toxicol       Date:  2018-12-06       Impact factor: 2.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.